About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study of the Sars-Cov2 Neuroinvasiveness - COVID19

NCT04427254·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Fondation Ophtalmologique Adolphe de Rothschild

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

COVID-19 patients requiring an external ventricular drain, a decompressive craniectomy or an intracranial hematoma surgery

You may not be if

Pregnant or lactating women

The record

StatusTerminated

PhaseNo phase

Taking part2

StartedJun 2020

UpdatedJul 11, 2023

Conditions

Where1

Fondation A de Rothschild
Paris, France

Clareo Health | Study of the Sars-Cov2 Neuroinvasiveness - COVID19